{"key":"op_491_CN","page":{"url":"https://kz.bookimed.com/clinics/country=china/procedure=keytruda/","procedure":{"id":491,"slug":"keytruda","name":"Иммунотерапия Кейтрудой (Пембролизумаб)","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":203,"iso":"CN","name":"Қытай"},"currency":"USD","data_date":"2026-10-02"},"pages":{"clinics_url":"https://kz.bookimed.com/clinics/country=china/procedure=keytruda/","cost_url":"https://kz.bookimed.com/clinics/country=china/procedure=keytruda/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":4500,"to":7200,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":13500,"to":22000},"uk":{"from":7000,"to":10500},"by_technique":[{"technique":"Pembrolizumab monotherapy","technique_id":"pembrolizumab-monotherapy","price_from":4500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Pembrolizumab combined with chemotherapy","technique_id":"pembrolizumab-combined","price_from":5500,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Гуаңджоу","from":4000},{"city":"Шаңхай","from":4100}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":4500,"to":8000},{"country_iso":"FR","from":4200,"to":7000},{"country_iso":"GB","from":7000,"to":10500},{"country_iso":"US","from":13500,"to":22000},{"country_iso":"IL","from":4800,"to":6800},{"country_iso":"TR","from":2800,"to":7000},{"country_iso":"MX","from":3800,"to":5500},{"country_iso":"DE","from":6000,"to":8100},{"country_iso":"CA","from":6800,"to":9800},{"country_iso":"AE","from":5600,"to":8600},{"country_iso":"TH","from":3600,"to":4600},{"country_iso":"PL","from":4300,"to":5800},{"country_iso":"KR","from":4800,"to":7500},{"country_iso":"CZ","from":3600,"to":5300},{"country_iso":"AT","from":5800,"to":8400},{"country_iso":"ES","from":13500,"to":{"status":"missing","reason":"not_collected"}},{"country_iso":"IT","from":4300,"to":6700},{"country_iso":"AU","from":4800,"to":7400},{"country_iso":"IN","from":2500,"to":5200},{"country_iso":"MY","from":3800,"to":5400},{"country_iso":"VN","from":4300,"to":6200},{"country_iso":"BR","from":4500,"to":7000},{"country_iso":"EG","from":1500,"to":6300}],"base_country":"US","base_is_fallback":false},"savings":{"pct":67,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":2,"items":[{"id":436,"name":"Fuda Cancer Hospital","city":"Guangzhou","rating":4.6,"reviews_count":19,"accreditations":{"status":"missing","reason":"not_collected"},"rank":1,"has_procedure":true,"why_ranked":"On-site FoundationOne CDx testing profiles 324 tumour-driving genes to guide immunotherapy choice, plus combined immunotherapy (CIC) using the patient's own cultivated antibodies. JCI-accredited, affiliated with Jinan University.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":8342,"name":"Hainan Chengmei Hospital","city":"Hainan Province","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Joint Commission International"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":6,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":390,"slug":"guangzhou","name":"Гуаңджоу","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":4000,"profile":{"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":2015,"slug":"shanghai","name":"Шаңхай","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":4100,"profile":{"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic melanoma; adjuvant melanoma after resection","Non-small cell lung cancer (alone or with chemotherapy)","Head and neck squamous cell carcinoma","Classical Hodgkin lymphoma (relapsed/refractory)","Urothelial carcinoma","MSI-high/dMMR solid tumors including colorectal cancer","Other approved cancers (cervical, endometrial, gastric, renal, breast)","Merkel cell carcinoma"],"contraindications":["Prior severe hypersensitivity to pembrolizumab or its components","Pregnancy (can harm the fetus)","Severe active autoimmune disease needing immunosuppression (relative)","Active uncontrolled infection (relative; treat first)","Prior solid organ transplant (relative; graft rejection risk)"],"operation_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Dose (200 mg every 3 weeks or 400 mg every 6 weeks) infused over 30 minutes, plus brief observation."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":1,"max":35,"unit":"visits","qualifier":"Infusions every 3 or 6 weeks for up to about 2 years (35 three-weekly cycles) or until progression."},"stages":[{"code":"infusion_cycles","label":"Repeated intravenous pembrolizumab infusions every 3 or 6 weeks","after":{"min":0,"max":730,"unit":"days","qualifier":"Spans the whole course from the first infusion."}}],"qualifier":"Number of cycles depends on cancer type, regimen, response and tolerance."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Per infusion; given as an outpatient infusion with no overnight stay."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":2,"unit":"days","qualifier":"Outpatient infusion with no surgical recovery; usual activities resume within 0-2 days, depending on fatigue and side effects."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"Outpatient infusion with no wound; flying is possible once no reaction occurs and you feel well."},"back_to_work_days":{"min":0,"max":2,"unit":"days","qualifier":"Most return to usual activities within 0-2 days, depending on fatigue, side effects and cancer type."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"No procedural restriction; light activity encouraged. Strenuous exercise within about a week, limited by fatigue."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Best response often seen within 3-6 months; responses may deepen later."},"result_longevity":"In responders, benefit is often durable, lasting years and sometimes continuing after the course (up to about 2 years) ends. Duration depends on cancer type, stage and biomarkers.","main_risks":["Immune-related organ inflammation (lungs, colon, liver, thyroid, kidneys, skin)","Fatigue, rash, itching, diarrhea, nausea","Infusion-related reactions","Type 1 diabetes, adrenal or pituitary insufficiency","Myocarditis (rare)","Serious or fatal immune events needing steroids and interruption"],"complication_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Grade 3-5 treatment-related adverse events with monotherapy in pivotal trials; higher with chemotherapy or TKIs."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Overall survival at 5 years (advanced NSCLC, PD-L1 ≥50%)","value":31.9,"horizon":"5 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"No scarring is expected; at most there is a tiny, temporary mark at the IV cannulation site.","pain":"Minimal; only mild discomfort from IV cannulation. Side effects such as joint or muscle pain may occur in some patients.","preparation":["Confirmed cancer and approved indication; biomarker testing if relevant","Baseline blood tests: liver, kidney, thyroid, glucose","Baseline imaging for staging","Review of autoimmune history, transplant history and current medications","Pregnancy test and contraception counseling where relevant","Discussion of side effects and when to report symptoms urgently","Hepatitis B/C and HIV screening; exclude active tuberculosis","Baseline ECOG performance status assessment","Adequate venous access for intravenous infusion"],"recovery_timeline":[{"phase":"Infusion day","description":"About 30-minute IV infusion with brief observation; most patients go home the same day.","restrictions":{"status":"missing","reason":"not_collected"}},{"phase":"First days after each infusion","description":"Possible mild fatigue, rash or flu-like symptoms. Promptly report cough, breathlessness, severe diarrhea or rash, jaundice or weakness.","restrictions":{"status":"missing","reason":"not_collected"}},{"phase":"Ongoing treatment","description":"Cycles every 3 or 6 weeks with monitoring for delayed immune-related side effects, which can appear months into treatment or after it ends.","restrictions":["Do not self-treat immune-related symptoms; contact the oncology team"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":21,"max":42,"unit":"days","qualifier":"Clinical review and blood tests before each subsequent cycle (every 3 or 6 weeks depending on regimen)."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"First response imaging is typically about 6-12 weeks after starting treatment."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the medical team treating you has suitable qualifications","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check that you can ask the treating team questions about your treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Check that you are satisfied with the facilities and standards where you will be treated","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check how your aftercare will be coordinated once treatment is over","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C5","text":"Check whether follow-up care takes place at the same facility as the procedure","scope":"treatment_abroad","source":{"url":"https://www.cdc.gov/yellow-book/hcp/health-care-abroad/medical-tourism.html","host":"cdc.gov","quote":"Medical tourists should also know whether follow-up care is scheduled to occur at the same facility as the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"The clinic or hospital refuses to discuss the details of the treatment when asked","scope":"treatment_abroad","source":{"url":"https://www.rcseng.ac.uk/patient-care/cosmetic-surgery/having-surgery-abroad","host":"rcseng.ac.uk","quote":"Be wary of surgeons and hospitals that do not want to discuss the details of surgery with you.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Fevers or flu-like symptoms with a rash","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Contact your care team right away if you notice fevers or flu-like symptoms with a rash.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Allergic reaction to the medicine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.healthline.com/health/drugs/keytruda","host":"healthline.com","quote":"Call your doctor right away if you have an allergic reaction to Keytruda.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Any change in eyesight","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Tell your care team right away if you have any change in your eyesight.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Shortness of breath or trouble breathing","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Dry cough, shortness of breath or trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W5","text":"Chest pain or fast or irregular heartbeat","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Heart muscle inflammation—unusual weakness or fatigue, shortness of breath, chest pain, fast or irregular heartbeat.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Gives your home doctor information about your treatment and future care needs","document":"discharge letter for gp","source":{"url":"https://www.nhs.uk/using-the-nhs/nhs-services/hospitals/being-discharged-from-hospital/","host":"nhs.uk","quote":"You'll also be given a letter for your GP, providing information about your treatment and future care needs.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Tells any doctor the patient is on immunotherapy, so side effects are managed correctly","document":"immunotherapy wallet card","source":{"url":"https://www.ons.org/toolkits/immunotherapy-patient-wallet-card-1","host":"ons.org","quote":"The ONS Immunotherapy Patient Wallet Card is intended to communicate with healthcare providers who are not involved with a patient's cancer treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Liver function test","aliases":["Liver function test","liver","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Kidney function test","aliases":["Kidney function test","kidney","kidney function","renal function"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Thyroid function test","aliases":["Thyroid function test","thyroid","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood glucose test","aliases":["Blood glucose test","glucose","blood glucose"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Pregnancy test","aliases":["Pregnancy test"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test and contraception counseling where relevant"}],"what_it_checks":{"text":"Checks whether pregnancy is present because treatment can cause fetal harm","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Based on its mechanism of action, KEYTRUDA can cause fetal harm when administered to a pregnant woman.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis B test","aliases":["Hepatitis B test","Hepatitis B/C screening","hepatitis B screening","HBV","Hepatitis C test","hepatitis C screening","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","HIV screening","HIV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1","PD-L1 test results"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Shows PD-L1 protein in tumor cells, guiding immunotherapy choice","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"A PD-L1 test uses a sample of cancerous tumor tissue to measure how much of a protein called programmed-death ligand 1 (PD-L1) is found on the cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation varies with how the tumor sample is collected","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T10","name":"MSI test","aliases":["MSI test","MSI","microsatellite instability"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Checks tumor MSI-high status, which decides if Keytruda can treat it","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (CRC) for the treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer (CRC) as determined by an FDA-authorized test.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":2,"unit":"days","qualifier":"Most return to usual activities within 0-2 days, depending on fatigue, side effects and cancer type."},"complication_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Grade 3-5 treatment-related adverse events with monotherapy in pivotal trials; higher with chemotherapy or TKIs."},"contraindications":["Prior severe hypersensitivity to pembrolizumab or its components","Pregnancy (can harm the fetus)","Severe active autoimmune disease needing immunosuppression (relative)","Active uncontrolled infection (relative; treat first)","Prior solid organ transplant (relative; graft rejection risk)"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Per infusion; given as an outpatient infusion with no overnight stay."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"No procedural restriction; light activity encouraged. Strenuous exercise within about a week, limited by fatigue."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Best response often seen within 3-6 months; responses may deepen later."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"Outpatient infusion with no wound; flying is possible once no reaction occurs and you feel well."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":21,"max":42,"unit":"days","qualifier":"Clinical review and blood tests before each subsequent cycle (every 3 or 6 weeks depending on regimen)."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"First response imaging is typically about 6-12 weeks after starting treatment."}}],"indications":["Advanced or metastatic melanoma; adjuvant melanoma after resection","Non-small cell lung cancer (alone or with chemotherapy)","Head and neck squamous cell carcinoma","Classical Hodgkin lymphoma (relapsed/refractory)","Urothelial carcinoma","MSI-high/dMMR solid tumors including colorectal cancer","Other approved cancers (cervical, endometrial, gastric, renal, breast)","Merkel cell carcinoma"],"main_risks":["Immune-related organ inflammation (lungs, colon, liver, thyroid, kidneys, skin)","Fatigue, rash, itching, diarrhea, nausea","Infusion-related reactions","Type 1 diabetes, adrenal or pituitary insufficiency","Myocarditis (rare)","Serious or fatal immune events needing steroids and interruption"],"pain":"Minimal; only mild discomfort from IV cannulation. Side effects such as joint or muscle pain may occur in some patients.","preparation":["Confirmed cancer and approved indication; biomarker testing if relevant","Baseline blood tests: liver, kidney, thyroid, glucose","Baseline imaging for staging","Review of autoimmune history, transplant history and current medications","Pregnancy test and contraception counseling where relevant","Discussion of side effects and when to report symptoms urgently","Hepatitis B/C and HIV screening; exclude active tuberculosis","Baseline ECOG performance status assessment","Adequate venous access for intravenous infusion"],"recovery_timeline":[{"phase":"Infusion day","description":"About 30-minute IV infusion with brief observation; most patients go home the same day.","restrictions":[]},{"phase":"First days after each infusion","description":"Possible mild fatigue, rash or flu-like symptoms. Promptly report cough, breathlessness, severe diarrhea or rash, jaundice or weakness.","restrictions":[]},{"phase":"Ongoing treatment","description":"Cycles every 3 or 6 weeks with monitoring for delayed immune-related side effects, which can appear months into treatment or after it ends.","restrictions":["Do not self-treat immune-related symptoms; contact the oncology team"]}],"rehabilitation_days":{"min":0,"max":2,"unit":"days","qualifier":"Outpatient infusion with no surgical recovery; usual activities resume within 0-2 days, depending on fatigue and side effects."},"result_longevity":"In responders, benefit is often durable, lasting years and sometimes continuing after the course (up to about 2 years) ends. Duration depends on cancer type, stage and biomarkers.","revision_rate_pct":null,"scars":"No scarring is expected; at most there is a tiny, temporary mark at the IV cannulation site.","sessions_or_stages":{"sessions":{"min":1,"max":35,"unit":"visits","qualifier":"Infusions every 3 or 6 weeks for up to about 2 years (35 three-weekly cycles) or until progression."},"stages":[{"code":"infusion_cycles","label":"Repeated intravenous pembrolizumab infusions every 3 or 6 weeks","after":{"min":0,"max":730,"unit":"days","qualifier":"Spans the whole course from the first infusion."}}],"qualifier":"Number of cycles depends on cancer type, regimen, response and tolerance."},"success":{"metric":"Overall survival at 5 years (advanced NSCLC, PD-L1 ≥50%)","value":31.9,"unit":"percent","horizon":"5 years","population":"Adults with untreated advanced NSCLC, PD-L1 ≥50%, on pembrolizumab monotherapy","evidence_status":"limited"},"techniques":[{"name":"Pembrolizumab monotherapy","suits_whom":"Patients with suitable biomarkers (e.g., high PD-L1, MSI-high) or melanoma","recovery":"Outpatient infusion; no downtime in most patients."},{"name":"Pembrolizumab combined with chemotherapy","suits_whom":"Patients such as those with non-small cell lung cancer or other tumors where the combination is approved","recovery":"Added chemotherapy side effects can increase fatigue and recovery time after each cycle."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Dose (200 mg every 3 weeks or 400 mg every 6 weeks) infused over 30 minutes, plus brief observation."},"initial_assessment_documents":["Pathology report with histology","PD-L1, MSI or dMMR test results","Staging CT or PET-CT reports","Prior treatment and surgery summary","Recent blood tests with liver and thyroid function","Oncologist letter on autoimmune disease or ECOG status"],"travel_trips":{"min":2,"max":35,"one_trip_possible":false,"qualifier":"Each 3- or 6-weekly infusion needs a visit; stay 1-3 days per trip. Fewer if a local oncologist continues."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the medical team treating you has suitable qualifications","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Check that you can ask the treating team questions about your treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Check that you are satisfied with the facilities and standards where you will be treated","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C4","text":"Check how your aftercare will be coordinated once treatment is over","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Ensure you're clear about how your aftercare will be coordinated.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C5","text":"Check whether follow-up care takes place at the same facility as the procedure","scope":"treatment_abroad","source":{"url":"https://www.cdc.gov/yellow-book/hcp/health-care-abroad/medical-tourism.html","host":"cdc.gov","quote":"Medical tourists should also know whether follow-up care is scheduled to occur at the same facility as the procedure.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":403}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"The clinic or hospital refuses to discuss the details of the treatment when asked","scope":"treatment_abroad","source":{"url":"https://www.rcseng.ac.uk/patient-care/cosmetic-surgery/having-surgery-abroad","host":"rcseng.ac.uk","quote":"Be wary of surgeons and hospitals that do not want to discuss the details of surgery with you.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Fevers or flu-like symptoms with a rash","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Contact your care team right away if you notice fevers or flu-like symptoms with a rash.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Allergic reaction to the medicine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.healthline.com/health/drugs/keytruda","host":"healthline.com","quote":"Call your doctor right away if you have an allergic reaction to Keytruda.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Any change in eyesight","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Tell your care team right away if you have any change in your eyesight.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Shortness of breath or trouble breathing","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Dry cough, shortness of breath or trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W5","text":"Chest pain or fast or irregular heartbeat","urgency":"contact_clinic","general":false,"source":{"url":"https://my.clevelandclinic.org/health/drugs/20941-pembrolizumab-injection","host":"my.clevelandclinic.org","quote":"Heart muscle inflammation—unusual weakness or fatigue, shortness of breath, chest pain, fast or irregular heartbeat.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Gives your home doctor information about your treatment and future care needs","document":"discharge letter for gp","source":{"url":"https://www.nhs.uk/using-the-nhs/nhs-services/hospitals/being-discharged-from-hospital/","host":"nhs.uk","quote":"You'll also be given a letter for your GP, providing information about your treatment and future care needs.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Tells any doctor the patient is on immunotherapy, so side effects are managed correctly","document":"immunotherapy wallet card","source":{"url":"https://www.ons.org/toolkits/immunotherapy-patient-wallet-card-1","host":"ons.org","quote":"The ONS Immunotherapy Patient Wallet Card is intended to communicate with healthcare providers who are not involved with a patient's cancer treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your advanced lung cancer has spread to other body parts","name":"Targeted medicines for lung cancer","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment","host":"nhs.uk","quote":"Targeted medicines or immunotherapy are sometimes used to treat advanced lung cancer that has spread to other parts of the body.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"pembrolizumab-monotherapy","name":"Pembrolizumab monotherapy","how_it_works":{"text":"The antibody blocks immune-inhibiting signals, allowing an anti-tumor immune response","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=pembro","host":"nctr-crs.fda.gov","quote":"Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"pembrolizumab-combined","name":"Pembrolizumab combined with chemotherapy","how_it_works":{"text":"The antibody is administered with another cancer treatment to treat cancer","source":{"url":"https://api.fda.gov/drug/label.json?search=openfda.application_number:%22BLA761467%22&limit=1","host":"api.fda.gov","quote":"The most common adverse reactions (≥20%) in patients receiving intravenous pembrolizumab and axitinib were diarrhea, fatigue/asthenia, hypertension, hypothyroidism, decreased appetite, hepatotoxicity, palmar-plantar erythrodysesthesia, nausea, stomatitis/mucosal inflammation, dysphonia, rash, cough, and constipation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Liver function test","aliases":["Liver function test","liver","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Kidney function test","aliases":["Kidney function test","kidney","kidney function","renal function"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Thyroid function test","aliases":["Thyroid function test","thyroid","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Blood glucose test","aliases":["Blood glucose test","glucose","blood glucose"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood tests: liver, kidney, thyroid, glucose"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Pregnancy test","aliases":["Pregnancy test"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test and contraception counseling where relevant"}],"what_it_checks":{"text":"Checks whether pregnancy is present because treatment can cause fetal harm","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Based on its mechanism of action, KEYTRUDA can cause fetal harm when administered to a pregnant woman.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis B test","aliases":["Hepatitis B test","Hepatitis B/C screening","hepatitis B screening","HBV","Hepatitis C test","hepatitis C screening","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","HIV screening","HIV"],"kind":"lab","origin":[{"field":"preparation","text":"Hepatitis B/C and HIV screening; exclude active tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1","PD-L1 test results"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Shows PD-L1 protein in tumor cells, guiding immunotherapy choice","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"A PD-L1 test uses a sample of cancerous tumor tissue to measure how much of a protein called programmed-death ligand 1 (PD-L1) is found on the cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation varies with how the tumor sample is collected","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T10","name":"MSI test","aliases":["MSI test","MSI","microsatellite instability"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PD-L1, MSI or dMMR test results"}],"what_it_checks":{"text":"Checks tumor MSI-high status, which decides if Keytruda can treat it","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=mab","host":"nctr-crs.fda.gov","quote":"Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (CRC) for the treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer (CRC) as determined by an FDA-authorized test.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"}}},"techniques":[{"id":"pembrolizumab-monotherapy","name":"Pembrolizumab monotherapy","how_it_works":{"id":"H1","text":"The antibody blocks immune-inhibiting signals, allowing an anti-tumor immune response","source":{"url":"https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/9333c79b-d487-4538-a9f0-71b91a02b287/spl-doc?hl=pembro","host":"nctr-crs.fda.gov","quote":"Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2, releasing PD-1 pathway-mediated inhibition of the immune response, including the anti-tumor immune response.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with suitable biomarkers (e.g., high PD-L1, MSI-high) or melanoma","price_from":4500,"recovery":"Outpatient infusion; no downtime in most patients."},{"id":"pembrolizumab-combined","name":"Pembrolizumab combined with chemotherapy","how_it_works":{"id":"H1","text":"The antibody is administered with another cancer treatment to treat cancer","source":{"url":"https://api.fda.gov/drug/label.json?search=openfda.application_number:%22BLA761467%22&limit=1","host":"api.fda.gov","quote":"The most common adverse reactions (≥20%) in patients receiving intravenous pembrolizumab and axitinib were diarrhea, fatigue/asthenia, hypertension, hypothyroidism, decreased appetite, hepatotoxicity, palmar-plantar erythrodysesthesia, nausea, stomatitis/mucosal inflammation, dysphonia, rash, cough, and constipation.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients such as those with non-small cell lung cancer or other tumors where the combination is approved","price_from":5500,"recovery":"Added chemotherapy side effects can increase fatigue and recovery time after each cycle."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your advanced lung cancer has spread to other body parts","name":"Targeted medicines for lung cancer","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment","host":"nhs.uk","quote":"Targeted medicines or immunotherapy are sometimes used to treat advanced lung cancer that has spread to other parts of the body.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"British citizens can enter China without a visa for up to 30 days for business, tourism, family or friend visits, or transit, for a limited period","source":{"url":"https://www.gov.uk/foreign-travel-advice/china/entry-requirements","host":"gov.uk","quote":"Until 31 December 2026, you can enter China visa free for stays of up to 30 days for business, tourism, family or friend visits or transit.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"visa","audience":"us","volatile":true,"text":"US citizens must obtain a visa before arriving in China","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"You must obtain a visa prior to arriving in the People’s Republic of China (PRC).","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must expire at least 6 months after arrival in China and have 2 blank pages for visas and stamping","source":{"url":"https://www.gov.uk/foreign-travel-advice/china/entry-requirements","host":"gov.uk","quote":"To enter China, your passport must have an ‘expiry date’ at least 6 months after the date you arrive and 2 blank pages for visas and stamping.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V4","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport must have at least six months of validity remaining to enter China","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"Your passport must have at least six months' validity remaining.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"medicines","audience":"us","volatile":false,"text":"Carry prescription medication for China in its original packaging, along with the prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"Carry prescription medication in original packaging, along with the prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"hospital_payment","audience":"all","volatile":false,"text":"Hospitals in China often require payment in cash or by mobile payment app before treatment, including emergency cases","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/China.html","host":"travel.state.gov","quote":"Payment in cash or via mobile payment app for services is often required prior to treatment, including emergency cases.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V7","item":"emergency_number","audience":"all","volatile":false,"text":"Call 120 and ask for an ambulance in China","source":{"url":"https://www.gov.uk/foreign-travel-advice/china/health","host":"gov.uk","quote":"Call 120 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["azerbaijan","dominican-republic","egypt","germany","india","israel","italy","japan","malaysia","mexico","morocco","republic-of-korea","spain","switzerland","thailand","turkey","ukraine","united-states"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.6,"count":19,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>The cost of Immunotherapy with Keytruda (Pembolizumab) in China typically ranges from _op_491_price_from_ to _op_491_price_to_. Final expenses depend on the dosage per cycle, the total number of treatment sessions, and clinic-specific administration fees. In the US, similar procedures cost around _price_compare_US_average_ on average. Patients can achieve savings of approximately _price_percent_discount_% by seeking treatment in China. This therapy usually includes the medication, oncologist consultation, and intravenous administration.</p>\n\n<ul>\n<li><strong>Medication volume:</strong> Prices are generally calculated per 100mg vial, which influences the total cycle cost.</li>\n<li><strong>Assistance programs:</strong> Patient assistance programs in China can reduce effective annual treatment costs by 50%.</li>\n<li><strong>Regional variations:</strong> Costs in medical hubs like Guangzhou and Shenzhen may vary based on local insurance.</li>\n<li><strong>Domestic alternatives:</strong> Local PD-1 inhibitors may cost 70-80% less than the brand-name Keytruda imported drug.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> China offers some of the lowest global prices for brand-name Keytruda. JCI-accredited facilities like Fuda Cancer Hospital in Guangzhou combine this therapy with specialized minimally invasive techniques. Patients seeking advanced oncology care can find significant value here. The hospital serves over 30,000 international patients and specializes in late-stage cancer. This makes it a strategic choice for high-quality care at a lower entry price.</p>","faq":{"status":"missing","reason":"not_collected"},"h2":[{"text":"Бұл қалай жұмыс істейді","kind":"content"},{"text":"Қытайда иммунотерапияның кейтрудой (пембролизумаб) бағасы қанша? Қазір біліңіз","kind":"content"},{"text":"Қытайда ең жақсы Иммунотерапия Кейтрудой (Пембролизумаб) клиникаларын ашыңыз: 2 тексерілген опциялар және бағалар","kind":"content"},{"text":"Қытайда иммунотерапияның кейтрудой (пембролизумаб) процедурасына шолу","kind":"content"},{"text":"Қытайда иммунотерапияның кейтрудой (пембролизумаб) медициналық бағалауын алыңыз: 6 тәжірибелі дәрігерлер кеңесіңіз","kind":"content"},{"text":"Bookimed науқастарының бейне тарихтары","kind":"content"},{"text":"Bookimed туралы пікірлер: науқастардың нақты тәжірибесімен танысыңыз","kind":"content"},{"text":"Осы контентпен бөлісу","kind":"content"},{"text":"Иммунотерапияда кейтрудой (пембролизумаб) туралы негізгі фактілер","kind":"content"},{"text":"Тегін консультация алу","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}